Cargando…

A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines

The presence of a carbohydrate moiety on asparagine 297 in the Fc part of an IgG molecule is essential for its effector functions and thus influences its vaccine protective effect. Detailed structural carbohydrate analysis of vaccine induced IgGs is therefore of interest as this knowledge can prove...

Descripción completa

Detalles Bibliográficos
Autores principales: Vestrheim, Anne Cathrine, Moen, Anders, Egge-Jacobsen, Wolfgang, Reubsaet, Leon, Halvorsen, Trine Grønhaug, Bratlie, Diane Bryant, Paulsen, Berit Smestad, Michaelsen, Terje Einar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217548/
https://www.ncbi.nlm.nih.gov/pubmed/25400928
http://dx.doi.org/10.1002/iid3.22
_version_ 1782342404453433344
author Vestrheim, Anne Cathrine
Moen, Anders
Egge-Jacobsen, Wolfgang
Reubsaet, Leon
Halvorsen, Trine Grønhaug
Bratlie, Diane Bryant
Paulsen, Berit Smestad
Michaelsen, Terje Einar
author_facet Vestrheim, Anne Cathrine
Moen, Anders
Egge-Jacobsen, Wolfgang
Reubsaet, Leon
Halvorsen, Trine Grønhaug
Bratlie, Diane Bryant
Paulsen, Berit Smestad
Michaelsen, Terje Einar
author_sort Vestrheim, Anne Cathrine
collection PubMed
description The presence of a carbohydrate moiety on asparagine 297 in the Fc part of an IgG molecule is essential for its effector functions and thus influences its vaccine protective effect. Detailed structural carbohydrate analysis of vaccine induced IgGs is therefore of interest as this knowledge can prove valuable in vaccine research and design and when optimizing vaccine schedules. In order to better understand and exploit the protective potential of IgG antibodies, we carried out a pilot study; collecting serum or plasma from volunteers receiving different vaccines and determining the IgG subclass glycosylation patterns against specific vaccine antigens at different time points using LC-ESI-MS analysis. The four vaccines included a pneumococcal capsule polysaccharide vaccine, a meningococcal outer membrane vesicle vaccine, a seasonal influenza vaccine, and a pandemic influenza vaccine. The number of volunteers was limited, but the results following immunization indicated that the IgG subclass which dominated the response showed increased galactose and the level of sialic acid increased with time for most vaccinees. Fucose levels increased for some vaccinees but in general stayed relatively unaltered. The total background IgG glycosylation analyzed in parallel varied little with time and hence the changes seen were likely to be caused by vaccination. The presence of an adjuvant in the pandemic influenza vaccine seemed to produce simpler and less varied glycoforms compared to the adjuvant-free seasonal influenza vaccine. This pilot study demonstrates that detailed IgG glycosylation pattern analysis might be a necessary step in addition to biological testing for optimizing vaccine development and strategies.
format Online
Article
Text
id pubmed-4217548
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42175482014-11-04 A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines Vestrheim, Anne Cathrine Moen, Anders Egge-Jacobsen, Wolfgang Reubsaet, Leon Halvorsen, Trine Grønhaug Bratlie, Diane Bryant Paulsen, Berit Smestad Michaelsen, Terje Einar Immun Inflamm Dis Original Research The presence of a carbohydrate moiety on asparagine 297 in the Fc part of an IgG molecule is essential for its effector functions and thus influences its vaccine protective effect. Detailed structural carbohydrate analysis of vaccine induced IgGs is therefore of interest as this knowledge can prove valuable in vaccine research and design and when optimizing vaccine schedules. In order to better understand and exploit the protective potential of IgG antibodies, we carried out a pilot study; collecting serum or plasma from volunteers receiving different vaccines and determining the IgG subclass glycosylation patterns against specific vaccine antigens at different time points using LC-ESI-MS analysis. The four vaccines included a pneumococcal capsule polysaccharide vaccine, a meningococcal outer membrane vesicle vaccine, a seasonal influenza vaccine, and a pandemic influenza vaccine. The number of volunteers was limited, but the results following immunization indicated that the IgG subclass which dominated the response showed increased galactose and the level of sialic acid increased with time for most vaccinees. Fucose levels increased for some vaccinees but in general stayed relatively unaltered. The total background IgG glycosylation analyzed in parallel varied little with time and hence the changes seen were likely to be caused by vaccination. The presence of an adjuvant in the pandemic influenza vaccine seemed to produce simpler and less varied glycoforms compared to the adjuvant-free seasonal influenza vaccine. This pilot study demonstrates that detailed IgG glycosylation pattern analysis might be a necessary step in addition to biological testing for optimizing vaccine development and strategies. Blackwell Publishing Ltd 2014-08 2014-05-22 /pmc/articles/PMC4217548/ /pubmed/25400928 http://dx.doi.org/10.1002/iid3.22 Text en © 2014 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Vestrheim, Anne Cathrine
Moen, Anders
Egge-Jacobsen, Wolfgang
Reubsaet, Leon
Halvorsen, Trine Grønhaug
Bratlie, Diane Bryant
Paulsen, Berit Smestad
Michaelsen, Terje Einar
A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title_full A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title_fullStr A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title_full_unstemmed A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title_short A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
title_sort pilot study showing differences in glycosylation patterns of igg subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217548/
https://www.ncbi.nlm.nih.gov/pubmed/25400928
http://dx.doi.org/10.1002/iid3.22
work_keys_str_mv AT vestrheimannecathrine apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT moenanders apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT eggejacobsenwolfgang apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT reubsaetleon apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT halvorsentrinegrønhaug apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT bratliedianebryant apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT paulsenberitsmestad apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT michaelsenterjeeinar apilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT vestrheimannecathrine pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT moenanders pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT eggejacobsenwolfgang pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT reubsaetleon pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT halvorsentrinegrønhaug pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT bratliedianebryant pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT paulsenberitsmestad pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines
AT michaelsenterjeeinar pilotstudyshowingdifferencesinglycosylationpatternsofiggsubclassesinducedbypneumococcalmeningococcalandtwotypesofinfluenzavaccines